These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24725652)

  • 1. Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.
    Kao AC; Rojnic Kuzman M; Tiwari AK; Zivkovic MV; Chowdhury NI; Medved V; Kekin I; Zai CC; Lieberman JA; Meltzer HY; Bozina T; Bozina N; Kennedy JL; Sertic J; Müller DJ
    J Psychiatr Res; 2014 Jul; 54():36-42. PubMed ID: 24725652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.
    Srisawat U; Reynolds GP; Zhang ZJ; Zhang XR; Arranz B; San L; Dalton CF
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):485-90. PubMed ID: 24229535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.
    van Winkel R; Moons T; Peerbooms O; Rutten B; Peuskens J; Claes S; van Os J; De Hert M
    Int Clin Psychopharmacol; 2010 Sep; 25(5):270-6. PubMed ID: 20523222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
    Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.
    Misiak B; Laczmanski L; Sloka NK; Szmida E; Slezak R; Piotrowski P; Kiejna A; Frydecka D
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):207-212. PubMed ID: 27932499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia.
    Kuzman MR; Müller DJ
    Pharmacogenomics; 2012 Jun; 13(8):843-6. PubMed ID: 22676185
    [No Abstract]   [Full Text] [Related]  

  • 7. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
    Zintzaras E
    Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR and risk of metabolic syndrome in patients with schizophrenia.
    van Winkel R; Rutten BP; Peerbooms O; Peuskens J; van Os J; De Hert M
    Schizophr Res; 2010 Aug; 121(1-3):193-8. PubMed ID: 20547447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults.
    Zappacosta B; Graziano M; Persichilli S; Di Castelnuovo A; Mastroiacovo P; Iacoviello L
    Cell Biochem Funct; 2014 Jan; 32(1):1-4. PubMed ID: 24277487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan.
    Wu HC; Chang CH; Tsai RY; Lin CH; Wang RF; Tsai CW; Chen KB; Yao CH; Chiu CF; Bau DT; Lin CC
    Anticancer Res; 2010 Sep; 30(9):3573-7. PubMed ID: 20944139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
    Tiwari AK; Rodgers JB; Sicard M; Zai CC; Likhodi O; Freeman N; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1484-90. PubMed ID: 20732371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
    Roffeei SN; Reynolds GP; Zainal NZ; Said MA; Hatim A; Aida SA; Mohamed Z
    Hum Psychopharmacol; 2014 Jan; 29(1):38-45. PubMed ID: 24424705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
    Sazci A; Ergul E; Kucukali I; Kara I; Kaya G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1113-23. PubMed ID: 16084002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
    Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
    Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
    Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia.
    Roffman JL; Weiss AP; Purcell S; Caffalette CA; Freudenreich O; Henderson DC; Bottiglieri T; Wong DH; Halsted CH; Goff DC
    Biol Psychiatry; 2008 Jan; 63(1):42-8. PubMed ID: 17543893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.